Literature DB >> 2818263

Painful oculomotor nerve palsy due to dural-cavernous sinus shunt.

S H Hawke1, M A Mullie, W F Hoyt, J M Hallinan, G M Halmagyi.   

Abstract

Two patients presented with painful unilateral oculomotor nerve palsies without evidence of ocular congestion or hypoxia. They were initially thought to have posterior communicating or distal internal carotid aneurysms, but had, in fact, dural-cavernous sinus shunts, draining posteriorly into the inferior petrosal sinus. One patient later developed a moderately severe congestive ophthalmopathy, and repeated selective carotid arteriograms showed that the shunt was now draining anteriorly into the superior ophthalmic vein. In the other patient, the oculomotor nerve palsy resolved without the development of any further signs. These observations support the concept that dural-cavernous sinus shunts produce symptoms that are dependent on the direction of drainage from the shunt. It is clear that the direction of drainage can change and that thrombosis of the posterior cavernous sinus determines the direction of drainage. The exact mechanism of the cranial neuropathy is, however, unknown.

Entities:  

Mesh:

Year:  1989        PMID: 2818263     DOI: 10.1001/archneur.1989.00520470126040

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  3 in total

Review 1.  Cavernous sinus fistulas: carotid cavernous fistulas and dural arteriovenous malformations.

Authors:  Leonard Feiner; Jeffrey Bennett; Nicholas J Volpe
Journal:  Curr Neurol Neurosci Rep       Date:  2003-09       Impact factor: 5.081

2.  Clinical and angiographic factors related to the prognosis of cavernous sinus dural arteriovenous fistula.

Authors:  Keun-Hwa Jung; Bae Ju Kwon; Kon Chu; Young Noh; Soon-Tae Lee; Young-Dae Cho; Moon Hee Han; Jae-Kyu Roh
Journal:  Neuroradiology       Date:  2010-12-16       Impact factor: 2.804

3.  Diabetes plus third nerve palsy not always diabetic third nerve palsy.

Authors:  P E Venkatesan; G Gnanashanmugam; N Parimalam; M B Pranesh
Journal:  J Postgrad Med       Date:  2015 Jan-Mar       Impact factor: 1.476

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.